IL48824A - Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type - Google Patents

Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type

Info

Publication number
IL48824A
IL48824A IL48824A IL4882476A IL48824A IL 48824 A IL48824 A IL 48824A IL 48824 A IL48824 A IL 48824A IL 4882476 A IL4882476 A IL 4882476A IL 48824 A IL48824 A IL 48824A
Authority
IL
Israel
Prior art keywords
tetrahydrocanabinol
derivatives
type
pharmaceutical compositions
compositions containing
Prior art date
Application number
IL48824A
Other languages
English (en)
Other versions
IL48824A0 (en
Inventor
Lander Naftali
R Mechoulam
Dikstein Shabtai
B Shalita
Original Assignee
Yissum Res Dev Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yissum Res Dev Co filed Critical Yissum Res Dev Co
Priority to IL48824A priority Critical patent/IL48824A/xx
Publication of IL48824A0 publication Critical patent/IL48824A0/xx
Priority to US05/755,083 priority patent/US4179517A/en
Priority to CA269,104A priority patent/CA1114828A/en
Priority to DE19772700340 priority patent/DE2700340A1/de
Priority to JP228777A priority patent/JPS52113976A/ja
Priority to GB1069/77A priority patent/GB1562972A/en
Priority to FR7700734A priority patent/FR2361383A1/fr
Publication of IL48824A publication Critical patent/IL48824A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78Ring systems having three or more relevant rings
    • C07D311/80Dibenzopyrans; Hydrogenated dibenzopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, ***e

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
IL48824A 1976-01-12 1976-01-12 Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type IL48824A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
IL48824A IL48824A (en) 1976-01-12 1976-01-12 Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
US05/755,083 US4179517A (en) 1976-01-12 1976-12-28 Novel tetrahydrocannabinol type compounds
CA269,104A CA1114828A (en) 1976-01-12 1977-01-04 Tetrahydrocannabinol type compounds
DE19772700340 DE2700340A1 (de) 1976-01-12 1977-01-05 Verbindungen vom tetrahydrocannabinol- typ und diese enthaltende arzneimittel
JP228777A JPS52113976A (en) 1976-01-12 1977-01-11 Pharmaceutical composition
GB1069/77A GB1562972A (en) 1976-01-12 1977-01-12 Tetrahydrocannabinols
FR7700734A FR2361383A1 (fr) 1976-01-12 1977-01-12 Derives de tetrahydrocannabinols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL48824A IL48824A (en) 1976-01-12 1976-01-12 Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type

Publications (2)

Publication Number Publication Date
IL48824A0 IL48824A0 (en) 1976-03-31
IL48824A true IL48824A (en) 1980-05-30

Family

ID=11048649

Family Applications (1)

Application Number Title Priority Date Filing Date
IL48824A IL48824A (en) 1976-01-12 1976-01-12 Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type

Country Status (7)

Country Link
US (1) US4179517A (xx)
JP (1) JPS52113976A (xx)
CA (1) CA1114828A (xx)
DE (1) DE2700340A1 (xx)
FR (1) FR2361383A1 (xx)
GB (1) GB1562972A (xx)
IL (1) IL48824A (xx)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL55274A (en) * 1978-08-02 1982-08-31 Yissum Res Dev Co 4-(2,6-dihydroxy-4-(dimethylheptyl)phenyl)substituted 2-pinen-10-ol and pinane derivatives,their preparation and pharmaceutical compositions comprising them
US4442089A (en) * 1982-07-06 1984-04-10 E. R. Squibb & Sons, Inc. Method for treating glaucoma with topical or systemic ACE inhibitor compositions
US4826812A (en) * 1982-12-27 1989-05-02 Schering Corporation Antiglaucoma agent
IL80411A (en) * 1986-10-24 1991-08-16 Raphael Mechoulam Preparation of dibenzopyranol derivatives and pharmaceutical compositions containing them
IL92238A (en) * 1989-11-07 1995-07-31 Yissum Res Dev Co ADMN blocking product containing tetrahydrocannabinol history, several new tetrahydrocannabinol histories and process for their preparation
US5284867A (en) * 1989-11-07 1994-02-08 Yissum Research Development Company Of The Hebrew University In Jerusalem NMDA-blocking pharmaceutical compositions
US5521215A (en) * 1989-11-07 1996-05-28 Ramot University Authority For Applied Research And Industrial Development Ltd. NMDA-blocking pharmaceuticals
US6096740A (en) * 1990-11-06 2000-08-01 Ramot University Authority For Applied Research And Industrial Development Ltd. Dexanabinol derivatives and their use as neuroprotective pharmaceutical compositions
US5635530A (en) * 1991-09-12 1997-06-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them
US5538993A (en) * 1991-09-12 1996-07-23 Yissum Research Development Company Certain tetrahydrocannabinol-7-oic acid derivatives
GB9807639D0 (en) * 1998-04-14 1998-06-10 Kennedy Rheumatology Inst Anti-inflammatory agents
ATE247097T1 (de) * 1998-05-04 2003-08-15 Univ Connecticut Analgetische und immunomodulierende cannabinoiden
US5847128A (en) * 1998-05-29 1998-12-08 Virginia Commonwealth University Water soluble derivatives of cannabinoids
US7589220B2 (en) * 1998-06-09 2009-09-15 University Of Connecticut Inhibitors of the anandamide transporter
US7897598B2 (en) * 1998-06-09 2011-03-01 Alexandros Makriyannis Inhibitors of the anandamide transporter
US7161016B1 (en) 1998-11-24 2007-01-09 University Of Connecticut Cannabimimetic lipid amides as useful medications
US7276613B1 (en) 1998-11-24 2007-10-02 University Of Connecticut Retro-anandamides, high affinity and stability cannabinoid receptor ligands
US7393842B2 (en) * 2001-08-31 2008-07-01 University Of Connecticut Pyrazole analogs acting on cannabinoid receptors
US8084467B2 (en) * 1999-10-18 2011-12-27 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US7741365B2 (en) * 1999-10-18 2010-06-22 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
US6943266B1 (en) * 1999-10-18 2005-09-13 University Of Connecticut Bicyclic cannabinoid agonists for the cannabinoid receptor
US6900236B1 (en) 1999-10-18 2005-05-31 University Of Connecticut Cannabimimetic indole derivatives
US7119108B1 (en) * 1999-10-18 2006-10-10 University Of Connecticut Pyrazole derivatives as cannabinoid receptor antagonists
US6995187B1 (en) 1999-10-18 2006-02-07 University Of Connecticut Peripheral cannabinoid receptor (CB2) selective ligands
EP1361876A4 (en) * 2001-01-26 2004-03-31 Univ Connecticut NEW CANNABIMIMETIC LIGANDS
CA2436133A1 (en) 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles
WO2002076480A1 (es) * 2001-03-28 2002-10-03 Floripes Medina Gallo Extracto de cannabis sativa para el tratamiento de la migraña
EP1414775B1 (en) * 2001-07-13 2012-12-19 The University of Connecticut Bicyclic cannabinoid
JP2005510492A (ja) * 2001-10-26 2005-04-21 ユニバーシティ オブ コネチカット 新規な種類の効力のあるカンナビミメティックリガンド
US20040171613A1 (en) * 2001-12-27 2004-09-02 Japan Tobacco Inc. Therapeutic agent for non-immediate type allergic diseases
WO2003075917A1 (en) * 2002-03-08 2003-09-18 Signal Pharmaceuticals, Inc. Combination therapy for treating, preventing or managing proliferative disorders and cancers
US20050137251A1 (en) * 2002-03-18 2005-06-23 Aaron Garzon Dexanabinol and dexanabinol analogs regulate inflammation related genes
AU2003265663A1 (en) 2002-08-23 2004-03-11 University Of Connecticut Keto cannabinoids with therapeutic indications
JP2006524247A (ja) * 2003-04-24 2006-10-26 マリンクロッド・インコーポレイテッド (+)−p−メンタ−2,8−ジエン−1−オールの製造方法
CA2573859A1 (en) * 2004-07-19 2006-01-26 Cilag Ltd. Method for obtaining pure tetrahydrocannabinol
EP1928853A4 (en) 2005-09-29 2011-02-16 Amr Technology Inc PROCESS FOR THE PRODUCTION OF DELTA-9-TETRAHYDROCANNABINOL
US9585867B2 (en) 2015-08-06 2017-03-07 Charles Everett Ankner Cannabinod formulation for the sedation of a human or animal

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4025516A (en) * 1975-06-23 1977-05-24 The John C. Sheehan Institute For Research, Inc. Process for the preparation of (-)-6a,10a-trans-6a,7,8,10a-tetrahydrodibenzo[b,d]-pyrans

Also Published As

Publication number Publication date
JPS52113976A (en) 1977-09-24
CA1114828A (en) 1981-12-22
GB1562972A (en) 1980-03-19
FR2361383B1 (xx) 1980-04-18
FR2361383A1 (fr) 1978-03-10
US4179517A (en) 1979-12-18
IL48824A0 (en) 1976-03-31
DE2700340A1 (de) 1977-07-21

Similar Documents

Publication Publication Date Title
IL48824A (en) Pharmaceutical compositions containing (3s,js) tetrahydrocanabinol derivatives and some novel compounds of this type
NZ185884A (en) Derivatives of 1,2,3,4-tetrahydronaphthalene and pharmaceutical compositions containing them
IL54754A0 (en) Novel hydantion compounds and pharmaceutical compositions containing them
ZA771003B (en) Pharmaceutical compositions containing pyrethrinoides
GB1524578A (en) Aminobenzoamide compounds and pharmaceutical compositions containing them
IL55774A (en) Pharmaceutical compositions containing urea derivatives,certain such novel derivatives and their manufacture
IL60243A (en) Pharmaceutical compositions containing 4-heteroaroyl and aroylimidazol-2-ones,some novel compounds of this type and their preparation
JPS532471A (en) Production of antiibacterial compound and pharmaceutical composition containing same
IL59770A (en) Pharmaceutical compositions containing 3-alkoxy-flavone derivatives,some novel compounds of this type and their preparation
IL55043A (en) Phytobactericidal compositions containing 6-fluoro-4-oxoquinole-3-carboxylic acid derivatives and some new such compounds
IL51301A0 (en) Novel oxygenated n-aryl-diazacyclic compounds their manufacture and pharmaceutical compositions containing them
IL51339A0 (en) New beta-lactam containing compounds their preparation and pharmaceutical compositions containing them
IL49325A0 (en) Novel prostaglandin derivatives,their preparation and pharmaceutical compositions containing them
IL52227A (en) Process for the preparation of 10,19-dihydro-vitamin d derivatives and some novel 10,19-dihydro-1alpha-hydroxy and 1 alpha,25-dihydroxy-vitamin d3 compounds and pharmaceutical compositions containing them
IL52717A0 (en) Novel derivatives of 2-phenylamino-imidazoline-(2), their preparation and pharmaceutical compositions containing them
IL53078A0 (en) New aryl sulphur compounds their preparation and pharmaceutical compositions containing them
IL55254A0 (en) Novel bis-isoquinolinium compounds,their preparation and pharmaceutical compositions containing them
IL50127A0 (en) Pharmaceutical compositions containing 2,1,3-benzothiadiazole derivatives
IL46893A (en) Pharmaceutical compositions containing 4-oxo- benzopyran-6-etanol or 6-acetic acid derivatives, certain novel compounds of this type and their preparation
IL53606A0 (en) Novel polyene compounds their manufacture and pharmaceutical compositions containing them
PH14398A (en) Pharmaceutical compounds,compositions containing same and method of use
IL54949A (en) Pharmaceutical compositions containing 4-hydroxy-2-oxoquinoline-3-carboxylic acid derivatives and novel compounds of this type
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
IL48439A (en) N-substituted-4-hydroxy-2h-naphtho-(2,1-e)1,2-thiazine-3-carboxamide-1,1-dioxide derivatives,their prparation and pharmaceutical compositions containing them
IL57476A0 (en) Compounds of the muramy-peptide type and pharmaceutical compositions containing them